OCT 03, 2020 9:32 PM PDT

Treating Gut-Leakiness

WRITTEN BY: Nouran Amin

A drug called tofacitinib, also called Xeljanz , was found to treat permeability defects in the intestines. Tofacitinib is an FDA-approved drug known to treat rheumatoid arthritis and ulcerative colitis.

Ulcerative colitis is an inflammatory bowel disease currently affecting 1 million Americans. It is a chronic disease causing leakiness in the large intestine.

Learn more:

"Our work could help improve identification of patients who will be better responders to this drug," says biomedical scientist Declan F. McCole at the University of California, Riverside.

The drug was found to reduce the expression "protein tyrosine phosphatase non-receptor Type 2," or PTPN2.

"Patients with the loss-of-function mutations in PTPN2 have an increased risk of inflammatory bowel disease," McCole said. "Our work improves our understanding of how this drug is useful for treating ulcerative colitis and suggests that patients with loss-of-function mutations in the PTPN2 gene may have a better response to tofacitinib. This could help with improved targeting of drug treatments to specific groups of patients."

Findings were published Journal of Crohn's and Colitis.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
SEP 10, 2020
Drug Discovery & Development
Improving Chemotherapeutic Delivery
SEP 10, 2020
Improving Chemotherapeutic Delivery
One particular form of stubborn cancer, known as hepatocellular carcinoma, has been challenging to treat and as a result ...
SEP 21, 2020
Drug Discovery & Development
WHO Endorses Clinical Trials for Herbal Medicines to Treat COVID-19
SEP 21, 2020
WHO Endorses Clinical Trials for Herbal Medicines to Treat COVID-19
The World Health Organization has endorsed a protocol to put African herbal medicines through clinical trials as possibl ...
SEP 21, 2020
Drug Discovery & Development
Metformin Does Not Work in All Type 2 Diabetics
SEP 21, 2020
Metformin Does Not Work in All Type 2 Diabetics
Although metformin is the first-line drug for type-2 diabetics, research shows that it is not always effective for all t ...
OCT 03, 2020
Cannabis Sciences
Cannabis Compound Prevents Colon Cancer in Mice
OCT 03, 2020
Cannabis Compound Prevents Colon Cancer in Mice
Second only to skin cancer, colon cancer is the most common cancer diagnosed in both men and women in the US. Now, resea ...
NOV 08, 2020
Drug Discovery & Development
Psychedelic Mushrooms Effectively Treat Major Depression
NOV 08, 2020
Psychedelic Mushrooms Effectively Treat Major Depression
Over 17 million people in the US and 300 million people worldwide are estimated to have experienced major depression. No ...
NOV 18, 2020
Technology
Using Machine Learning to Build Chemical Libraries
NOV 18, 2020
Using Machine Learning to Build Chemical Libraries
Using machine learning in drug discovery is no longer a novel procedure and has been well documented in recent literatur ...
Loading Comments...